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Abstract
Phlebotomy is one of the most complex medical procedures in the diagnosis, management and treatment of patients in healthcare. Since laboratory 
test results are the basis for a large proportion (60-80%) of medical decisions, any error in the phlebotomy process could have serious consequences. 
In order to minimize the possibility of errors, phlebotomy procedures should be standardised, well-documented and written instructions should be 
available at every workstation. Croatia is one of the few European countries that have national guidelines for phlebotomy, besides the universally 
used CLSI (Clinical Laboratory Standards Institute) H3-A6 Procedures for the Collection of Diagnostic Blood Specimens by Venipuncture; approved 
Standard-Sixth Edition (CLSI, 2007) and WHO (World Health Organization) guidelines on drawing blood: best practices in phlebotomy (WHO, 2010). 
However, the growing body of evidence in importance of preanalytical phase management resulted in a need for evidence based revision and ex-
pansion of existing recommendations.
The Croatian Society for Medical Biochemistry and Laboratory Medicine, Working Group for the Preanalytical Phase issued this recommendation. 
This document is based on the CLSI guideline H3-A6, with significant differences and additional information.
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Today, the analytical phase of laboratory work is 
perfected through automation. Errors in laborato-
ry medicine occur most frequently in the extra-an-
alytical phase of laboratory testing (1). The preana-
lytical phase and especially pre-preanalytical 
phase are major sources of laboratory errors (2, 3). 
Out of all processes that happen outside the labo-
ratory (e.g. test ordering, patient preparation, 
blood sampling, transportation of samples), phle-
botomy is the most complex and most vulnerable 
to errors (4). Phlebotomy is a pivotal invasive pro-
cedure in diagnosis, management and treatment 
of patients in healthcare (5). Since a large propor-
tion (60-80%) of medical decisions is based on the 
results of the laboratory tests (6, 7), any error in the 
phlebotomy process could have serious conse-
quences primarily for the patients, but also for 
medical professionals and healthcare system in 
general (8).
Phlebotomy is a complex procedure and includes 
a large number of steps. Small variations in each of 
them can create a large cumulative effect. In addi-
tion, there is a large heterogeneity in the educa-
tion of medical staff performing phlebotomy 
(nurses, laboratory technicians, phlebotomists), in-
troducing another layer of variability into the sys-
tem (9). Therefore, in order to minimize the possi-
bility of errors, this procedure should be standard-
ised, well-documented and written instructions 
should be available at every workstation.
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Two key documents are used as phlebotomy 
guidelines worldwide: CLSI (Clinical Laboratory 
Standards Institute) H3-A6 Procedures for the Col-
lection of Diagnostic Blood Specimens by Veni-
puncture; Approved Standard-Sixth Edition (CLSI, 
2007) (10) and WHO (World Health Organization) 
Guidelines on Drawing Blood: Best Practices in 
Phlebotomy (WHO, 2010) (11). Some European 
countries are using these widely accepted stand-
ards, while some have nationally adopted/adjust-
ed/translated phlebotomy guidelines. Based on 
the recently published survey of the European 
Federation of Clinical Chemistry and Laboratory 
Medicine, Working Group for the Preanalytical 
Phase (EFLM WG-PA) (9), only seven European 
countries have national guidelines for phleboto-
my: Ireland (12), UK (13), Spain, Slovenia, Sweden 
(14), Italy and Croatia (15). The main reasons for not 
having national guidelines are: 1) lack of time or 
leadership to perform the work or 2) implementa-
tion of CLSI or WHO guidelines eliminated the 
need for national guidelines (9). However, based 
on the self-reported questionnaire, estimated 
compliance with the guidelines is poor, indicating 
the need for continuous education and implemen-
tation of existing procedures (16).
Although Croatia is one of the few European coun-
tries that already have national guidelines for phle-
botomy, the growing evidence supporting the im-
portance of preanalytical phase management re-
sulted in a need for evidence-based revision and 
an expansion of existing recommendations.
Background and scope
In Croatia, clinical chemistry is a recognized and 
regulated profession and is almost exclusively 
practiced by specialists in medical biochemistry 
and laboratory medicine (17). Only medical profes-
sionals work in laboratories. Venous blood sam-
pling is performed in hospital wards, primary care 
offices and laboratories. While nurses perform 
blood sampling in hospital wards and primary care 
dispensaries, in medical laboratories blood sam-
pling is performed by laboratory technicians and 
bachelors of medical laboratory diagnostics. Dur-
ing high school education for laboratory techni-
cians, students are required to comprehend theo-
retic and practical principles of phlebotomy, how-
ever a specialised course in phlebotomy is not part 
of the curriculum (9). Phlebotomy is not thought of 
in higher forms of education in clinical chemistry 
(undergraduate and graduate), and even special-
ists are not required to be qualified to perform 
phlebotomy. In addition, there is no specific train-
ing in phlebotomy as a continuous educational re-
course. The scope of medical biochemistry and 
laboratory medicine in Croatia includes clinical bi-
ochemistry, haematology, coagulation, toxicology 
and therapeutic drug monitoring, immunology 
and molecular diagnostics. Fields outside of the 
scope of profession are microbiology, blood-bank-
ing and cytogenetics (17).
This recommendation was issued by the Croatian 
Society for Medical Biochemistry and Laboratory 
Medicine, Working Group for the Preanalytical 
Phase after a review of relevant literature sources 
in phlebotomy procedures. Although other medi-
cal professionals (i.e. nurses and physicians) can 
use this document, it is intended primarily for lab-
oratory staff when performing venous blood sam-
pling within medical biochemistry laboratories. 
This document is based on the CLSI guideline H3-
A6 (10), however there are some significant differ-
ences. In Croatian laboratories, blood sampling us-
ing catheters is never performed; therefore, that 
part of CLSI H3-A6 guideline is omitted. In addi-
tion, since evacuated tubes are generally accepted 
as standard and are used in almost every labora-
tory in Croatia, blood sampling with syringes is not 
described in this document. As stated earlier, 
microbiology is not within the scope of medical 
biochemistry in Croatia, thus parts referring to 
microbiology testing are significantly shortened. 
Certain procedures are modified according to 
some recent evidence in the field of preanalytics. 
Additional information is provided and rationale 
for modification in comparison with the CLSI H3-
A6 guideline is explained in highlighted boxes. In 
addition, some instructions (i.e. order of draw and 
requirements for mixing) are specified for manu-
facturers of phlebotomy supplies that are most 
commonly used  in Croatia: BD - Becton, Dickinson 
and Company (Franklin Lakes, NJ, USA) and Grein-
er Bio-One (Kremsmünster, Austria).
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Materials
Before performing venipuncture it is essential to 
properly prepare the workplace and have undis-
turbed access to all necessary supplies. A well-or-
ganized workplace ensures continuous workflow 
of all procedures. All supplies should only be used 
until the declared expiry date. Each phlebotomy 
site should contain following materials:
Written procedure for blood sampling•	
Alcoholic (ethanol, isopropyl alcohol) and non-•	
alcoholic (benzine) disinfectants
Test request form•	
Evacuated blood collection tubes with various •	
additives and volume sizes
Safe-sharp needles of different gauge size, •	
based on the physical characteristics of the 
vein, location of the vein and volume of drawn 
blood




Adhesive bandages or tapes•	
Gloves•	




Water bath at 37 °C.•	
Procedure
Sanitizing hands
The phlebotomist should sanitize his hands imme-
diately before the first contact with the patient, us-
ing warm water and soap or disinfectant gels, tis-
sues or foams according to the nationally accepted 
guidelines (18). This approach ensures that all sur-
faces touched by phlebotomists prior to venipunc-
ture are free of pathogens.
Inspecting test request form
It is advisable to modify the test request form ac-
cording to ISO 15189 requirements (19). Request 
form should include, but not be limited to, the fol-
lowing information:
Name, surname, gender, date of birth and con-•	
tact details (address, telephone number) of the 
patient and unique identifier (health insurance 
number or personal identification number)
Identification of the doctor who requested ex-•	
aminations and contact details (address of pri-
mary healthcare provider or hospital ward full 
name)
Requested tests•	
Any clinically relevant information about the •	
patient, his preparation and therapy in order to 
properly conduct examinations and interpret 
the results. 
In comparison with the CLSI H3-A6 guideline, 
we have separated data that should be present 
on the test request form for the samples drawn 
outside the laboratory.
For blood samples drawn outside the laborato-
ry, test request form should, in addition, contain 
following items:
Date and time of sample collection;•	
Name of the medical staff who performed •	
collection;
Type of primary sample (i.e. full blood, serum, •	
plasma), additive (if any), and where relevant, 
anatomic origin of the sample.
Identifying the patient
Identification of the patient is the key point in pa-
tient laboratory processing (20, 21). Proper identifi-
cation relies on at least two independent identifi-
cations (22). Data from the request form should 
never be solely used for identification. Patient 
identification should be performed according to 
following instructions:
Phlebotomist should ask the patient to state •	
the full name, address and/or birth date. The 
questions should be phrased as such: “Please 
state your name” and “Please state your date of 
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birth;” not “Are you John Smith?” and “Is your 
birth date June 1, 1977”
Compare obtained information with the infor-•	
mation on the request form
Any discrepancies should be reported, record-•	
ed and resolved before sample collection.
There are circumstances that may limit proper pa-
tient identification, such as unconscious or semi-
conscious patients, children that are too young, 
deaf and cognitively impaired patients or non-na-
tive speakers. In such cases, identification of the 
patient must be completed with the assistance of 
ward nurse, legal guardian, parent or accompany-
ing person. All data must be identical with the data 
on the request form and the name of the person 
who verified identity must be documented.
Verifying patient preparation for venipuncture
Preparing the supplies for blood sampling
This section brings additional information in 
comparison with the CLSI guideline H3-A6. CLSI 
guideline only verifies the patient’s fasting sta-
tus. It is recommended that laboratory staff ver-
ify the patient’s preparation for laboratory test-
ing, including specific preparation for certain 
tests. Lack of this information can result in acquir-
ing an inadequate sample for analysis. Results 
from unsuitable specimens are not reliable.
In comparison with the CLSI H3-A6 guideline, 
the use of blood sampling devices other than 
evacuated blood tubes is not described. There-
fore, syringes are not listed as necessary equip-
ment. In addition, since Croatia is a European 
Union member, an EU Council Directive 2010/32/
EU (35) applies for handling sharp medical de-
vices and is added and referenced in the text. 
Patient preparation before sample collection is es-
sential for accurate test results. Depending on re-
quested examinations, patient preparation usually 
involves special diet restrictions or therapy proto-
cols. Depending on the tests ordered, a list of 
questions that the phlebotomist should ask the 
patient before venipuncture is provided in Table 1. 
If the patient is not properly prepared for sample 
collection, the phlebotomist should inform him of 
the effects on the laboratory results and postpone 
the venipuncture giving the patient all informa-
tion needed for proper preparation. If, for some 
reason, phlebotomy cannot be postponed, ob-
served nonconformity should be documented on 
the request form and comment provided on the 
laboratory report.
All required materials must be assembled prior to 
venipuncture and according to requested tests. 
Only supplies with an appropriate expiry date 
must be available to the phlebotomist and the 
handling procedure must minimize the possibility 
of occupational exposure. The supplies that should 
be available are:
Evacuated blood collection tubes with various •	
additives. Tubes of various volume sizes should 
be available. Tube volume size should be ad-
justed to the number of requested tests, since 
excessive blood drawing volume can cause 
anaemia in patients if the blood sampling is 
done frequently (36).
Needles of appropriate gauge size, based on •	
the physical characteristics of the vein, location 
of the vein and volume of drawn blood. Differ-
ent gauge sizes should be available. Using inad-
equate needle gauge size can cause hemolysis 
of the sample (37). According to EU Council Di-
rective 2010/32/EU (35) all medical devices 
should be safety-engineered in order to in-
crease safety of healthcare workers and mini-
mize risk of professional injury.
Winged blood collection sets. These sets are •	
used for blood drawing in children or in pa-




Alcoholic (ethanol, isopropyl alcohol) and non-•	
alcoholic (benzene) disinfectants
Adhesive bandages or tapes•	
Gloves - it is mandatory to use single-use •	
gloves
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All Fasting When did you have your last meal? A large proportion of laboratory tests are influenced by 
dietary intake (23). Also, lipemia of the sample can cause 
interference in measurement even for analytes that are 
not influenced by fasting status (24).
All Fasting Only water drinking is allowed prior to 
venipuncture.
Did you have anything else to drink this 
morning?
Most drinks contain sugar that could influence the 
results of glucose measurement. In addition, a large 
proportion of drinks contain active substances that can 
affect laboratory tests with known (i. e. enzyme induction 




Are you taking any vitamins, food 
supplements, herbal or natural based 
medicines?
These supplements may have known or unknown biological 
effects, medicinal effects, or even technical effects on 
measuring (e.g. vitamin C in faecal occult blood test, 
riboflavin in dipstick urine testing). Any information about 
taking these supplements should be documented (26,27).
All Patient 
position
Were you resting for 15 minutes prior to 
blood sampling?
If patient is excited and is not rested prior to blood 
sampling, increased production of hormones (i.e. 
catecholamines and corticosteroids) can alter 




Therapy Are you receiving any kind of anticoagulant 
therapy? 
PT INR should be measured prior to taking OAT. Also, 
thrombophilia screening tests (LAC, protein C, protein 
S, APCR) cannot be performed if the patient is already 





What is the current day of your menstrual 
cycle?
Concentration of female hormones depends on the day of 
the menstrual cycle (26).
Homocysteine Dietary 
habits
Are you fasting for 12 hours? Did you have 
protein-rich meal within last 48 hours?
Protein-rich meals can cause falsely elevated 
homocysteine concentration (29). 
Iron Therapy Were you receiving any oral or intravenous 
supplements containing iron within the 
last 10 days? 
Consumption of iron supplements or too little time after 
discontinuing of taking those preparations causes falsely 
elevated iron concentration (26).
Lipid status Dietary 
habits
When did you have your last meal? Did you 
have any changes in diet within the last two 
weeks? Did you consume alcohol within the 
last 48 hours? Were you engaged in extreme 
physical activity within the last 48 hours?
For the measurement of the lipid status, compliance 
to the recommended protocol is required since any 
discrepancies influence results of the measurement and, 




Therapy Do you have your usual therapy with you (i. 
e. insulin or oral hypoglycaemics)? 
When performing measurement of postprandial glucose, 
the patient should simulate an everyday meal and therapy 
regime. If receiving oral hypoglycaemics, the patient 
should take their meal and therapy after sampling for 
fasting glucose has been done. Deviation from the usual 




Therapy When did you take last dose of the drug? 
What is the name of the drug you are 
receiving?
Therapeutic drug monitoring should be done after the 
drugs are at a steady state and blood collection performed 
immediately prior to taking the next dose of the drug (32). 
The time of the application of the previous dose will help 
to interpret results of the test. Errors in interpretation can 




Therapy When did you take last dose of 
levothyroxine?
Levothyroxine should not be taken in the morning before 
blood sampling is done, since hormones cause falsely 
elevated concentration of T4/freeT4 (34).
PT INR - prothrombin time, international normalized ratio; OAT - oral anticoagulant therapy; LAC - lupus anticoagulant; APCR - acti-
vated protein C resistance
Table 1. Verification of patient’s preparation for venipuncture.
http://dx.doi.org/10.11613/BM.2013.031 Biochemia Medica 2013;23(3):242–54 
  247
Nikolac N, et al. CSMBLM: recommendations for phlebotomy
Container for disposal of used needles after •	
venipuncture. This container should also be in 




Venipuncture should always be performed on the 
patient sitting or lying down. For patient safety as-
surance, it is advisable that chairs have arm hold-
ers. The arm must be supported by the armrest. 
During the venepuncture, the patient should not 
have any foreign objects in the mouth (chewing 
gum, thermometer etc.).
Putting on gloves
Although CLSI guideline H3-A6 resolutely states 
that tubes must be labelled after the collection, 
there is no undisputable evidence to support 
that recommendation. Therefore, this document 
recommends tube labelling just after identifica-
tion of the patient and verification of his appro-
priate preparation for the laboratory testing and 
prior to venipuncture procedure. If the tube is to 
be labelled after venipuncture, it should be 
done in front of the patient, while he is still sit-
ting in front of the phlebotomist. Otherwise, 
there is possibility that the tube will be left unla-
belled.
Several pieces of data should be documented for 
each venipuncture:
Patient’s first and last name•	
Patient’s date of birth•	
Laboratory identification number•	
Patient’s health insurance identification •	
number
Time and date of sampling•	
Identification of phlebotomist.•	
Not all of them have to be listed on the tube, but 
they all have to be documented in a way so that 
the tube is traceable and unambiguously connect-
ed to the patient, collected sample or phleboto-
mist. It is recommended that the tube is labelled 
with a barcode, as barcodes can contain all above-
mentioned information. If not on the tube, this in-
formation should be recorded in the paper docu-
mentation or laboratory information system.
It is recommended that the tube is identified with 
at least two independent pieces of information. 
The more information present on the tube, the 
more the patient’s safety is increased and the pos-
sibility of patient identification errors is reduced.
CLSI H3-A6 guideline recommends putting 
gloves on after applying tourniquet. However, 
there is evidence that the time of tourniquet ap-
plication on patient’s hand is longer than the 
recommended 60 seconds (38). In order to re-
duce potential errors that may occur because of 
prolonged blood stasis (39-41), we propose 
putting on gloves prior to tourniquet applica-
tion.
Before each venipuncture, the phlebotomist 
should put on gloves. The phlebotomist should 
use new gloves for each patient.
Applying tourniquet
A tourniquet is used for easier location of the vein. 
It increases intravascular pressure and makes veins 
more visible, which reduces the possibility of erro-
neous puncture and possible damage of local ar-
teries and nerves. Tourniquets should never be ap-
plied for longer than one minute, in order to avoid 
local hemoconcentration that may result in erro-
neous laboratory findings. When the tourniquet is 
applied for longer than one minute, it should be 
released and reapplied after minimum two min-
utes. Tourniquets should be applied between 7 
and 10 cm above the venipuncture site. If the skin 
has lesions where tourniquet is to be applied a dif-
ferent venipuncture site must be considered. Al-
ternatively, a tourniquet can be applied over the 
gauze pad, tissue or patient’s clothes. For better 
visualization of the preferred puncture site, the pa-
tient can form a fist. However, the patient should 
not pump his hand vigorously. It should be noted 
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that the tourniquet must not be applied when 
specific tests are required, because blood stasis 
can significantly alter concentrations of certain an-
alytes: lactate (10), ammonia (42), albumin (43) and 
calcium (43).
Selecting venipuncture site
The preferred venipuncture sites are antecubital 
veins that lie near the skin surface. When those 
veins are not available, venipuncture can be per-
formed on the veins on the back of the hand. Veins 
on the underside of the wrist are not recommend-
ed for venipuncture, because the arteries and ten-
dons are too close to the skin surface. Arterial 
punctures should never be considered as an alter-
native for difficult venipuncture without consult-
ing the physician first. Blood should never be 
drawn from sites of extensive scaring, on the hand 
on the side on which mastectomy was performed, 
hematoma (if not avoidable the sample should be 
drawn distal to the hematoma), arm with an intra-
venous therapy application, cannula, fistula and 
vascular graft.
There are two basic vein distributions in antecu-
bital fossa, H and M shaped patterns. Names of the 
patterns are based on the shapes that form most 
prominent veins of that area, cephalic, median 
chepalic, median cubital, median basilic and basil-
ic vein (Figure 1).
The selection of the vein for blood collection must 
be done carefully. Median cubital and median 
veins should be considered first for venipuncture. 
If those veins are not accessible, the cephalic vein 
should be considered next. Basilic veins are to be 
considered last for venipuncture, as they are too 
close to the brachial artery and median nerve. Any 
form of discrepancy from recommended veni-
puncture procedure should be documented. There 
should be written procedures available for dealing 
with the accidental artery puncture or nerve dam-
age.
With the aid of the tourniquet, the phlebotomist 
should palpate the selected vein with the index 
finger. The thumb should not be used, because it 
has a pulse beat. Palpation also helps in differenti-
ating veins from arteries.
Cleaning venipuncture site
After selecting the vein, the venipuncture site 
must be properly disinfected, in order to avoid mi-
crobial contamination of the patient and collected 
sample. The skin is cleaned with sterile cotton or 
gauze pads with 70% isopropyl alcohol or ethanol. 
The skin should be cleansed with circular motions 










Figure 1. Veins of the Forearm. 
CLSI guideline H3-A6 states that disinfectant 
should be left to dry before performing veni-
puncture in order to avoid possible hemolysis 
and avoid patient discomfort. However, evi-
dence has shown that this procedure is often 
unattended in practise (44). In addition, there is 
no evidence that hemolysis rate will increase if 
the venipuncture is done immediately after ap-
plying disinfectant (45). Therefore, we recom-
mend that, in order to reduce time of tourniquet 
application, it is not necessary to wait for disin-
fectant to dry.
When blood alcohol determination is requested, a 
non-alcoholic based disinfectant should be used, 
often ether or benzine. When there are difficulties 
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with venipuncture and the vein must be palpated 
again, the skin should be cleansed again. Special 
consideration must be given to the duration of 
tourniquet application.
Performing venipuncture
The recommended blood collection sets are those 
with evacuated tube systems.
Place a cotton or gauze pad on the wound and •	
remove the needle from the vein.
Dispose of the needle.•	
Inform patient to press cotton or gauze pad on •	
the wound.
Bandage the venipuncture site (see section •	
Bandaging the skin after venipuncture).
When all the tubes are drawn, mix the tubes ac-•	
cording to recommendations (see section Tube 
mixing).
Order of draw
When collecting more than one tube special at-
tention has to be given to order of draw. This rec-
ommendation is crucial, in order to avoid additive 
or anticoagulant carryover and to avoid potential 
tissue contamination. Failure to follow this proce-
dure could result in significant errors (46, 47).
The recommended order of draw for different 
types of tubes (with or without gel, with or with-
out additive) is shown in Table 2.
Clot activators or tissue factors released during 
venipuncture can affect coagulation testing. 
Therefore, the coagulation tube has to be drawn 
before any other tube with additive.
This recommendation does not suggest blood 
drawing using syringes; therefore, this drawing 
technique is omitted in comparison to CLSI 
guideline H3-A6.
For the proper venipuncture technique, the manu-
facturer’s instructions should be followed. Veni-
puncture should be performed as follows:
Place the appropriate needle into the needle •	
holder.
Position the patient’s arm in a downward posi-•	
tion to prevent reflux from the collection tube 
into the vein.
Hold the patient’s arm distal to the puncture •	
site. Use the thumb to anchor the vein 2.5 to 5 
cm below the venipuncture site.
Inform the patient that venipuncture is about •	
to occur.
Insert the needle at the angle 30° or less and •	
keep it stable in the vein.
Connect the first tube onto the needle.•	
As soon as blood starts to fill the tube, release •	
the tourniquet.
Allow the tube to fill until blood flow ceases. •	
This ensures correct blood volume and ratio of 
blood to additive.
Remove the full tube from the needle and re-•	
place it with the next tube (if any).
When collecting several tubes, always follow •	
the recommended order of draw (see section 
Order of draw).
Always remove the last tube from the needle •	
holder before removing the needle from the 
vein.
CLSI guideline H3-A6 recommends that a dis-
card tube should be drawn if coagulation assays 
other than prothrombin time, international nor-
malized ratio and activated partial thromboplas-
tin time should be determined. However, there 
is published evidence in the literature that there 
is no difference in the results of other special-
ized coagulation tests determined with and 
without discard tube (50-53). Therefore, this rec-
ommendation does not support CLSI H3-A6 rec-
ommendation of drawing a discard tube for 
specialized coagulation tests.
However, when using winged blood collection set 
and any coagulation test is requested, then the 
discard tube has to be drawn prior to the coagula-
tion tube. This ensures proper anticoagulant and 
blood ratio, which can be compromised because 
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Tube/Additive Top colour Top colour legend
Blood culture tube Various
Glass or plastic non-additive serum tube (without clot activator) Red1, white2
Coagulation tube Light blue1,2
Serum tube 
Gel separator tube Red1, gold1,2
Tube without gel Red1,2






Without gel separator Lavander1,2
With gel separator Lavander1,2, white2
ESR tubes Black1,2
Glycolysis inhibitor tubes Gray1,2
Other tubes that contain anticoagulants or additives
Top colours are adjusted to most commonly used manufacturers in Croatia: 1BD (Becton, Dickinson and Company, 
Franklin Lakes, NJ, USA) and 2Greiner Bio-One (Grainer Bio-One, Kremsmünster, Austria). 
EDTA - ethylenediaminetetraacetic acid; ESR - erythrocyte sedimentation rate.
Table 2. Order of draw (10, 48, 49).
Figure 2. One mixing cycle.
air in the system can cause under filling of coagu-
lation tube (54).
Needle disposing
Disposable equipment used in collection proce-
dure has to be properly removed according to 
manufacturer’s recommendations. Needles have 
to be immediately disposed into the sharps con-
tainer according to local regulations (35).
Any potential injuries or blood contamination of 
the personnel during or after the phlebotomy proc-
ess should be handled according to institution poli-
cies. Written documents explaining procedures 
should be available at each phlebotomy site.
Tube mixing
Since all tubes generally contain some kind of ad-
ditive (anticoagulant or clot activator), all of them 
have to be properly mixed immediately after col-
lection. The exception is a glass BD serum tube 
with clot activator (all Greiner Bio-One tubes are 
plastic and all should be mixed). Recommenda-
tions for proper tube mixing given by two manu-
facturers commonly used in our country are given 
in Table 3. Mixing cycle stands for one full inver-
sion of the tube (180°) and returning the tube to 
the initial position (Figure 2). Full inversion is when 
the air bubble moves from one end of the tube to 
the other.
Bandaging the skin after venipuncture
After blood collection, the phlebotomist should 
gently put cotton or gauze pads over the venipunc-
ture site and then remove the needle. The patient 
has to hold the pad on the vein and should not 
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bend their arm. After 30 seconds to 1 minute (when 
all tubes are properly mixed), the phlebotomist 
should bandage the arm and advise the patient to 
hold the bandage for at least 15 minutes. In case of 
prolonged (longer than 5 minutes) or excessive 
bleeding, the physician should be noted and more 
pressure should be applied until bleeding stops. 
Personnel involved in phlebotomy should be edu-
cated to help patient in case of emergencies like 
fainting, nausea, vomiting or convulsions. There sho-
uld be written procedure for handling such cases.
Removing gloves
Dispose of the gloves after venipuncture.
Recording additional information
Laboratory staff should record any nonconformity 
that occurs during the phlebotomy according to 
laboratory protocol.
Special handling requirements
Some specimens need special handling proce-
dures after blood collection. There are thermola-
bile analytes or those that are sensitive to light ex-
posure. Analytes that require special handling dur-
ing transportation to the laboratory are listed in 
Table 4.
In addition to Table 4, laboratory managers are re-
quired to follow any additional manufacturer’s rec-
ommendations regarding special handling condi-
tions.
Additional considerations
Phlebotomy for a child younger than six years 
should be done with previous consultation with 
physician. Special attention has to be paid to ap-
propriate equipment for venipuncture of children. 
All before stated steps in phlebotomy procedure 
must be applied when collecting blood from a 
child. This recommendation does not refer to col-
lection of capillary blood by skin puncture.
Flowchart
A step-by-step phlebotomy procedure is present-
ed in Figure 3.
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Manufacturer Number of tubeinversions Tube type (additive)
Grainer Bio-One 
tube mixing
3-4 Coagulation test (citrate tubes)
8
Serum tubes with clot activator or gel, plasma heparin or EDTA tubes with clot activator or 
gel, whole blood EDTA tubes, ESR tubes, trace elements tubes (all kind), blood group tubes 
(ACD additive), tubes with glycolysis inhibitor
BD tube mixing
0 Glass serum tube with clot activator 
3-4 Coagulation test (citrate tubes)
5 Plastic serum tube with clot activator and gel
8
Serum tube with thrombine based clot activator, plasma heparin or EDTA tubes with clot 
activator or gel, whole blood EDTA tubes, ESR tubes, trace elements tubes (all kind), blood 
group tubes (ACD additive), tubes with glycolysis inhibitor
EDTA - ethylenediaminetetraacetic acid; ESR - erythrocyte sedimentation rate; ACD - acid citrat dextrose; BD - Becton, Dickinson 
and Company).
Table 3. Recommendations for tube mixing by two manufacturers commonly used in Croatia - BD (Becton, Dickinson and Company, 
Franklin Lakes, NJ, USA) and Greiner Bio-One (Kremsmünster, Austria).
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Table 4. Analytes that require special handling procedures af-
ter blood collection.












































wrapped in a foil 
immediately after 
collection and store 




























To chill a specimen, 
place it immediately in a 
mixture of ice and water 
(ice slurry not big ice 
cubes). Do not put the 
specimen in direct contact 
with ice or dry ice to 
avoid hemolysis. Chilling 
whole blood specimens 
for longer than two 
hours is contraindicated 
for determination of 
potassium levels.







For determination of 
cold agglutinins, an 
EDTA tube should be 
used. For cryofibrinogen 
and cryoglobulins, 
use tubes that do not 
contain any additives, all 
collection supplies must 
be pre-warmed, keep 
the sample at water bath 
heated at 37°C until serum 
can be separated from the 
cells, separate the serum 
from the cells within 1 
hour of collection.
ACE – angiotensin-converting enzyme. 









































Drawing other tubes 












venipuncture site Step 10
Selecting 
venipuncture site
Figure 3. Step-by-step phlebotomy procedure.
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